#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma metastatic Acute lymphocytic leukaemia Short stature Follicle centre lymphoma follicular grade I, II – III Systemic mastocytosis Hepatitis B Retinoblastoma HER2 gene amplification Rectal cancer Erythema Thymic carcinoma Warm autoimmune haemolytic anaemia Ovarian cancer stage IV Neovascular age-related macular degeneration Malignant fibrous histiocytoma More trials…

    Learn about Rare Diseases

    Gaucher’s disease type I – Treatment Pelizaeus-Merzbacher disease Progressive multifocal leukoencephalopathy – Treatment SAPHO syndrome – Basic Information Toxic epidermal necrolysis – Basic Information Biotinidase deficiency – Diagnostics Mantle cell lymphoma – Diagnostics Bronchopulmonary dysplasia Lymphangiosarcoma – Life with Disease Pituitary-dependent Cushing’s syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dipyridamole Busulfan Asciminib Hydrochloride Thiamazole Carbamazepine (Ph. Eur.) Jnj-77242113 HTL0022537 Treprostinil Palmitil Vortioxetine Hydrobromide Ethinylestradiol Riboflavin Bp Dabrafenib Mesylate Binimetinib Perindopril Arginine Florbetapir (18F) Phosphocreatine Sodium Valganciclovir GSKVX000000070248 Quercus Robur Pollen Extract Darbepoetin Alfa More therapies…

    Learn about Your Condition

    Skin bacterial infection Pancreatic carcinoma stage IV Bronchiectasis Asymptomatic HIV infection Pancreatitis relapsing Behavioural addiction Femur fracture Pyrexia Medulloblastoma Leiomyosarcoma metastatic Cutaneous sarcoidosis Pulmonary venous thrombosis HER2 positive breast cancer Hyperlipidaemia Type V hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Breslauer Strasse 201, Langwasser, Nürnberg, 90471, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Tenecteplase for Acute Ischemic Stroke in Patients Taking Direct Oral Anticoagulants

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Germany

  • Study of zanidatamab with drug combination for patients with HER2 and PD-L1 positive advanced gastroesophageal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Fluorouracil
    • Folic Acid
    • Oxaliplatin
    Germany

  • A Study of JNJ-78278343 Compared to Placebo for Patients with Advanced Prostate Cancer That No Longer Responds to Hormone Treatment

    Recruiting

    3 1
    Belgium France Germany Italy The Netherlands Poland +1

  • Testing dapagliflozin to slow kidney function decline in patients with autosomal dominant polycystic kidney disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Austria Germany The Netherlands Spain

  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Saruparib
    Austria Belgium Finland France Germany Hungary +5

  • A study testing tenecteplase given directly into the artery after blood clot removal in patients with acute ischemic stroke in the front part of the brain

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    Germany

  • Study comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • GSK5764227
    • Topotecan
    Bulgaria Finland France Germany Greece Hungary +7

  • Study of drug combination therapy after surgery in patients with resectable pancreatic ductal adenocarcinoma using lab-grown mini-tumors to guide treatment selection

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal squamous cell carcinoma
    Investigated Drugs:
    • Docetaxel
    • Ifinatamab Deruxtecan
    • Irinotecan Hydrochloride
    Belgium Denmark France Germany Italy The Netherlands +5

  • Study Comparing Ifinatamab Deruxtecan and Docetaxel for Patients with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Buclizine Hydrochloride
    • Codeine Phosphate
    Austria Czechia Denmark France Germany Greece +7
Previous Page
1 2 3 4 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!